Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
A TselisO Khan

Abstract

Patients with severe visual loss because of optic neuritis refractory to high dose corticosteroids have limited therapeutic options. The use of intravenous immunoglobulin (IVIG) has been advocated in the past, but data are scarce. In this study, we use a protocol different from those used in other studies, with different timing and dosage. Consecutive patients with corticosteroid-refractive optic neuropathy were treated with IVIG and compared with control patients who received only corticosteroids in an open-label, non-randomized, controlled prospective study. Twenty-three patients received treatment with IVIG and 24 matched patients who did not receive treatment with IVIG were followed as controls. All patients had visual acuity 20/400 or worse in the affected eye. There was significant improvement in the IVIG group with 18/23 (78%) subjects reaching near normal vision (20/30 or better), compared with the control group with only 3/24 (12.5%) responding similarly. The use of IVIG, following corticosteroids, may be useful using the protocol described herein, with sustained pulsed dosing. A larger controlled trial is indicated to confirm these results.

References

Dec 1, 1992·Annals of Neurology·B G van EngelenM Rodriguez
Jan 1, 1990·Annals of Neurology·M Rodriguez, V A Lennon
Nov 9, 2000·Neurology·J H NoseworthyM Rodriguez
Dec 15, 2004·Neurology·P Soelberg SorensenUNKNOWN TARIMS Study Group
Jan 13, 2006·Ophthalmology·Jennifer B FisherLaura J Balcer
Feb 24, 2006·Brain : a Journal of Neurology·Bertrand AudoinDavid H Miller
Jul 3, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·S VucicD Cros

❮ Previous
Next ❯

Citations

Aug 8, 2009·Der Nervenarzt·S SchwarzB Storch-Hagenlocher
Dec 18, 2013·Der Nervenarzt·H Steffen
Aug 13, 2013·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H Steffen
Dec 16, 2011·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Aditya SudhalkarBakulesh Khamar
Dec 23, 2011·Current Treatment Options in Neurology·Gabrielle R Bonhomme, Ellen B Mitchell
Dec 12, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Regina Berkovich
Jun 25, 2013·Trends in Pharmacological Sciences·Mathias ButtmannHans-Peter Hartung
Nov 1, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A Achiron
Aug 29, 2012·Clinical Ophthalmology·John H Pula, Christopher J Macdonald
Sep 19, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Aditya SudhalkarBakulesh Khamar
Feb 21, 2016·Clinical Neurology and Neurosurgery·R AlroughaniS Al-Shammri
Oct 28, 2015·Postgraduate Medical Journal·R SawayaR Hamam
May 5, 2012·Revue neurologique·D LaplaudUNKNOWN GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank)
May 14, 2011·Journal of Neuroimmunology·Xiaohong ChenLili Ma
Mar 29, 2011·Neurologic Clinics·Pavle Repovic, Fred D Lublin
Jan 21, 2010·Acta Neurologica Scandinavica·I Elovaara, A Hietaharju
Oct 31, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Jeffrey L BennettElliot M Frohman
Dec 18, 2013·Lancet Neurology·Ahmed T ToosyDavid H Miller
Feb 25, 2015·International Ophthalmology·M Garcia-GeremiasA D Dick
Dec 1, 2014·Brain : a Journal of Neurology·Laura J BalcerJeffrey A Cohen
Oct 10, 2009·Current Opinion in Ophthalmology·John H Pula, Adil Javed
Aug 28, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sven G MeuthHeinz Wiendl
Sep 28, 2012·Current Opinion in Ophthalmology·Nilufer Kale
Jul 13, 2019·Developmental Neurobiology·George G BastakisMaria Savvaki
Sep 23, 2009·Expert Review of Neurotherapeutics·Alexandra SchröderRalf Gold
Aug 4, 2016·Journal of Clinical Neurology·Jae Gun ParkMin Su Park
Feb 5, 2019·Biological & Pharmaceutical Bulletin·Hiroyuki TakahashiTsunefumi Kobayashi
Feb 9, 2011·Clinical Neuropharmacology·Irina ElovaaraBirgit Reipert
Dec 30, 2020·BMJ Case Reports·Andrew DermawanSherman Picardo
Dec 17, 2020·Indian Journal of Ophthalmology·Prathama SarkarMohit Kumar Gupta
Dec 30, 2009·Current Opinion in Neurology·George NtaiosPatrik Michel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.